Clinical Trials Browser

Phase 2 × Breast Neoplasms × ridaforolimus × Clear all

NCT01605396 2019-03-25

MK-8669-064

Phase 2 Completed

80 enrolled 13 charts

Breast Neoplasms

NCT00736970 2015-08-27

Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)

Phase 2 Completed

Breast Neoplasms